WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

Most people who stop GLP-1 drugs like Ozempic eventually return

Many people prescribed GLP-1 drugs for type 2 diabetes (such as Victoza, Ozempic, or tirzepatide) stop taking them, but a surprising number later return to treatment. Researchers found that newer medications appear to keep patients on therapy longer, while side effects remain a major reason for discontinuation.

Raccontata dagizmodo.comsciencedaily.com

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
sciencedaily.com1 mesi fa

Popular GLP-1 weight-loss drugs linked to lower risks of addiction and overdose

GLP-1 drugs reduce substance use disorder risk 14-25% and overdose mortality 50%, per 606k-veteran study validating broader therapeutic applications in addiction. Existing GLP-1 drugs may unlock addiction treatment via shared craving biology, shortcutting drug development cycles without new compound discovery.

Leggi questa versione → originale
gizmodo.com1 mesi fa

Can Ozempic Treat Alcoholism? Here's What You Should Know

A first Lancet RCT (26 weeks, n=100) found semaglutide reduced alcohol consumption and heavy drinking days vs placebo. The shared dopamine mechanism implies GLP-1s could address multiple addictions, reshaping Novo Nordisk's pipeline beyond obesity.

Leggi questa versione →

Timeline cronologica

  1. venerdì 29 maggio 2026·gizmodo.com

    Can Ozempic Treat Alcoholism? Here's What You Should Know

    A recent trial is the latest to suggest that GLP-1s aren't just for treating diabetes and obesity.

  2. lunedì 1 giugno 2026·sciencedaily.com

    Most people who stop GLP-1 drugs like Ozempic eventually return

    Many people prescribed GLP-1 drugs for type 2 diabetes (such as Victoza, Ozempic, or tirzepatide) stop taking them, but a surprising number later return to treatment. Researchers…

originale
  • lunedì 1 giugno 2026·sciencedaily.com

    Scientists discover why ozempic may not work for some people

    Scientists have identified genetic variants that may make some people less responsive to GLP-1 drugs used to treat Type 2 diabetes. Roughly 10% of the population carries these…

  • lunedì 1 giugno 2026·sciencedaily.com

    Popular GLP-1 weight-loss drugs linked to lower risks of addiction and overdose

    A massive study of more than 600,000 U.S. veterans suggests that popular GLP-1 drugs such as semaglutide may do far more than help with diabetes and weight loss—they could also…